Trials / Recruiting
RecruitingNCT05257551
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Tempus Small Cell Lung Cancer Observational Study (Sculptor): A Tissue and Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Small Cell Lung Cancer (SCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Tempus AI · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first and second line treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | No intervention |
Timeline
- Start date
- 2022-07-13
- Primary completion
- 2029-03-01
- Completion
- 2029-03-01
- First posted
- 2022-02-25
- Last updated
- 2026-04-02
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05257551. Inclusion in this directory is not an endorsement.